학술논문

Single-dose of adrecizumab versus placebo in acute cardiogenic shock (ACCOST-HH): an investigator-initiated, randomised, double-blinded, placebo-controlled, multicentre trial
Document Type
Article
Source
In: The Lancet Respiratory Medicine. (The Lancet Respiratory Medicine, March 2022, 10(3):247-254)
Subject
Language
English
ISSN
22132619
22132600